Public Joint-Stock Company "Pharmsynthez" (LIFE.ME)
RUB 4.22
(1.2%)
RUB 4.22
(1.2%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 379.67 Million | 438.33 Million | 371.65 Million | 117.39 Million | 281.76 Million | 723.5 Million |
| Cost of Revenue | 298.91 Million | 277.28 Million | 211.73 Million | 119.32 Million | 250.59 Million | 414.23 Million |
| Gross Profit | 80.75 Million | 161.04 Million | 159.92 Million | -1.92 Million | 31.17 Million | 309.26 Million |
| Operating Expenses | 217.1 Million | 330.17 Million | 201.33 Million | 241.04 Million | -35.53 Million | 1.26 Billion |
| Selling, General and Administrative Expenses | 43.66 Million | 87.22 Million | 67.98 Million | 7.16 Million | 35.04 Million | 344.63 Million |
| Research and Development Expenses | 16.79 Million | 54.18 Million | 46.51 Million | 5.77 Million | 69.59 Million | 268.87 Million |
| Other Expenses | 156.64 Million | 188.77 Million | 86.82 Million | 233.88 Million | -43.37 Million | 654.78 Million |
| Cost and Expenses | 547.15 Million | 607.46 Million | 413.06 Million | 360.37 Million | 215.05 Million | 1.68 Billion |
| Operating Income | -167.48 Million | -169.13 Million | -41.41 Million | -729.14 Million | 66.7 Million | -2.87 Billion |
| Interest Expense | 41.32 Million | 36.37 Million | 29.55 Million | 28.06 Million | 5.8 Million | 4.53 Million |
| Income Tax Expense | -1.22 Million | -35.85 Million | -2.39 Million | -64.72 Million | -57.95 Million | -71.29 Million |
| Earnings before Tax | -208.71 Million | -733.4 Million | -527.21 Million | -757.77 Million | 1.8 Million | -2.84 Billion |
| Net Income | -207.49 Million | -697.55 Million | -524.81 Million | -693.04 Million | 59.76 Million | -2.52 Billion |
| Earnings Per Share Basic | -0.69 | -2.32 | -1.74 | -2.40 | 0.21 | -9.13 |
| Earnings Per Share Diluted | -0.69 | -2.32 | -1.74 | -2.40 | 0.20 | -9.13 |
| Weighted Average Shares Outstanding | 300.71 Million | 301.01 Million | 301.01 Million | 289.18 Million | 289.18 Million | 276.12 Million |
| Weighted Average Shares Outstanding (Diluted) | 301.01 Million | 301.01 Million | 301.01 Million | 289.18 Million | 301.01 Million | 276.12 Million |
| Gross Margin | 0.21 | 0.37 | 0.43 | -0.02 | 0.11 | 0.43 |
| EBIT Margin | -0.37 | -0.73 | -0.98 | -6.21 | 0.13 | -3.81 |
| Profit Margin | -0.55 | -1.59 | -1.41 | -5.90 | 0.21 | -3.49 |
| EBITDA | -139.88 Million | -647 Million | -199.24 Million | -1.68 Billion | -213.49 Million | -1 Billion |
| Earnings Before Tax Margin | -0.44 | -0.39 | -0.11 | -6.21 | 0.24 | -3.98 |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 86.23 Million | 86.23 Million | 379.67 Million | 85.85 Million | 85.85 Million | 207.95 Million |
| Cost of Revenue | 59.45 Million | 59.45 Million | 298.91 Million | 75.6 Million | 75.6 Million | 147.65 Million |
| Gross Profit | 26.77 Million | 26.77 Million | 80.75 Million | 10.24 Million | 10.24 Million | 60.3 Million |
| Operating Expenses | 89.12 Million | 89.12 Million | 217.1 Million | 81.16 Million | 81.16 Million | 125.71 Million |
| Selling, General and Administrative Expenses | 49.14 Million | 49.14 Million | - | 44.7 Million | 44.7 Million | 105.89 Million |
| Research and Development Expenses | 5.47 Million | 5.47 Million | - | 1.1 Million | 1.1 Million | 19.01 Million |
| Other Expenses | - | - | 156.64 Million | - | - | -805 Thousand |
| Cost and Expenses | 148.58 Million | 148.58 Million | 516.02 Million | 156.77 Million | 156.77 Million | 273.36 Million |
| Operating Income | -23.31 Million | -23.31 Million | -136.35 Million | -33.75 Million | -33.75 Million | -65.4 Million |
| Interest Expense | - | - | 41.32 Million | - | - | 18.95 Million |
| Income Tax Expense | 10.91 Million | 10.91 Million | -1.22 Million | 12.05 Million | 12.05 Million | 22.88 Million |
| Earnings before Tax | -70.89 Million | -70.89 Million | -208.71 Million | -82.07 Million | -82.07 Million | -34.4 Million |
| Net Income | -81.8 Million | -81.8 Million | -207.49 Million | -70.02 Million | -70.02 Million | -67.44 Million |
| Earnings Per Share Basic | -0.27 | -0.27 | - | -0.24 | -0.24 | -0.22 |
| Earnings Per Share Diluted | -0.27 | -0.27 | - | -0.24 | -0.24 | -0.22 |
| Weighted Average Shares Outstanding | 302.98 Million | 302.98 Million | 301.01 Million | 295 Million | 295 Million | 301.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 302.98 Million | 302.98 Million | 301.01 Million | 295.43 Million | 295.43 Million | 301.01 Million |
| Gross Margin | 0.31 | 0.31 | 0.21 | 0.12 | 0.12 | 0.29 |
| EBIT Margin | -0.22 | -0.22 | - | -0.35 | -0.35 | -0.26 |
| Profit Margin | -0.95 | -0.95 | -0.55 | -0.82 | -0.82 | -0.32 |
| EBITDA | -19.2 Million | -19.2 Million | - | -29.66 Million | -29.66 Million | -53.68 Million |
| Earnings Before Tax Margin | -0.27 | -0.27 | -0.36 | -0.39 | -0.39 | -0.31 |
WFC-PC
ASG
300399
HMNF
0788
MON